Segment Information - Summary of Information by Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
External revenues	$ 17,400	$ 12,062	$ 47,245	$ 39,828
Operating expenses	126,843	113,449	381,933	326,670
Loss from operations	(109,443)	(101,387)	(334,688)	(286,842)
Unrestricted cash	70,686	39,735	70,686	39,735	$ 36,665
Sorrento Therapeutics
Segment Reporting Information [Line Items]
External revenues	6,023	4,537	21,130	17,515
Operating expenses	104,849	97,766	324,208	278,195
Loss from operations	(98,826)	(93,229)	(303,078)	(260,680)
Unrestricted cash	68,152	35,380	68,152	35,380
Scilex
Segment Reporting Information [Line Items]
External revenues	11,377	7,525	26,115	22,313
Operating expenses	21,994	15,683	57,725	48,475
Loss from operations	(10,617)	(8,158)	(31,610)	(26,162)
Unrestricted cash	$ 2,534	$ 4,355	$ 2,534	$ 4,355